Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T13:37:23.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-17T13:47:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:38:55.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study details with an access-restricted message. The detailed trial content for the study has been removed or hidden.
    Difference
    20%
    Check dated 2026-09-19T19:24:32.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now reflects a revision update from v3.6.5 to v3.6.6, indicating a small internal update. No substantive study details or content have changed.
    Difference
    0.0%
    Check dated 2026-08-29T18:55:49.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a minor patch to the page. There are no changes to study content or functionality reflected in this update.
    Difference
    0.0%
    Check dated 2026-08-08T10:47:10.000Z thumbnail image

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.